Moleculin Biotech (MBRX) Property, Plant & Equipment (Net) (2016 - 2026)
Moleculin Biotech (MBRX) reported Property, Plant & Equipment (Net) of $62,000 for Q2 2026, down 37.4% from $99,000 a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Property, Plant & Equipment (Net) (2016 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech posted Property, Plant & Equipment (Net) of $78,000, down 50.9% from FY2024.
- Property, Plant & Equipment (Net) has declined for five consecutive years, with a five-year compound annual growth rate of -30.6% (FY2020 to FY2025).
- By year, Property, Plant & Equipment (Net) came in at $159,000 in FY2024 (-41.5%), $272,000 in FY2023 (-1.1%), $275,000 in FY2022 (-18.6%) and $338,000 in FY2021 (-30.0%).
- The Q2 2026 figure ranks as the lowest quarterly Property, Plant & Equipment (Net) since Q2 2018.
- Over the past five years, the year-over-year decline in Property, Plant & Equipment (Net) ranged from 1.1% (Q4 2023) to 59.5% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 29.29 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 23.58 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 5.80 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 25.74 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 10.69 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 13.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 8.55 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 5.83 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 19.03 Bn |
| 10 | Moleculin Biotech | 2.78 Mn | 2.78 Mn | - | 62,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 99,000.00 |
| Mar 31, 2025 | 127,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Sep 30, 2024 | 190,000.00 |
| Jun 30, 2024 | 221,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 272,000.00 |
| Sep 30, 2023 | 225,000.00 |
| Jun 30, 2023 | 229,000.00 |
| Mar 31, 2023 | 244,000.00 |
| Dec 31, 2022 | 275,000.00 |
| Sep 30, 2022 | 306,000.00 |
| Jun 30, 2022 | 339,000.00 |
| Mar 31, 2022 | 312,000.00 |
| Dec 31, 2021 | 338,000.00 |
| Sep 30, 2021 | 353,000.00 |
| Jun 30, 2021 | 395,000.00 |
API Access
Moleculin Biotech Property, Plant & Equipment (Net) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "property-plant-and-equipment-net", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();